About this episode
近日，日本将由iPS（诱导多能干细胞）制备的心肌细胞片产品纳入公共医疗保险体系，这也是继今年5月帕金森治疗产品落地后，日本第二款进入全民医保的iPS再生医疗产品。曾经专属于极少数高净值人群的尖端再生医学，正在通过医保制度的普惠设计，真正走向普通重症患者。
Get every episode summarized
Each time 天方烨谈 publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
